Brought to you by 
Alza and Transform build optimization platform
14 Jun 2002
Executive Summary
TransForm Pharmaceuticals (technologies for discovering the best forms and formulations for drugs) and Alza Corp. (drug delivery company, now owned by Johnson & Johnson) will work together exclusively to develop a platform for optimizing the formulation of products in Alza's D-Trans transdermal delivery pipeline.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
-
Drug Delivery
- Transdermal
-
Drug Delivery
-
Biotechnology
- Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Alza and Transform build optimization platform
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice